202 related articles for article (PubMed ID: 19525245)
1. Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath.
Dieplinger B; Gegenhuber A; Haltmayer M; Mueller T
Heart; 2009 Sep; 95(18):1508-13. PubMed ID: 19525245
[TBL] [Abstract][Full Text] [Related]
2. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
Mueller T; Gegenhuber A; Poelz W; Haltmayer M
Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
[TBL] [Abstract][Full Text] [Related]
4. The incremental benefit of a shortness-of-breath biomarker panel in emergency department patients with dyspnea.
Singer AJ; Thode HC; Green GB; Birkhahn R; Shapiro NI; Cairns C; Baumann BM; Aghababian R; Char D; Hollander JE
Acad Emerg Med; 2009 Jun; 16(6):488-94. PubMed ID: 19388909
[TBL] [Abstract][Full Text] [Related]
5. Short-term mortality risk in emergency department acute heart failure.
Peacock WF; Nowak R; Christenson R; DiSomma S; Neath SX; Hartmann O; Mueller C; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Filippatos GS; Anand I; Ng LL; Daniels LB; Morgenthaler N; Anker SD; Maisel AS
Acad Emerg Med; 2011 Sep; 18(9):947-58. PubMed ID: 21906204
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
[TBL] [Abstract][Full Text] [Related]
7. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
[TBL] [Abstract][Full Text] [Related]
8. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Hartmann O; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2011 Aug; 58(10):1057-67. PubMed ID: 21867843
[TBL] [Abstract][Full Text] [Related]
9. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study.
Daniels LB; Clopton P; Potocki M; Mueller C; McCord J; Richards M; Hartmann O; Anand IS; Wu AH; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Filippatos GS; Di Somma S; Ng L; Neath SX; Christenson R; Morgenthaler NG; Anker SD; Maisel AS
Eur J Heart Fail; 2012 Jan; 14(1):22-31. PubMed ID: 22140234
[TBL] [Abstract][Full Text] [Related]
10. Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.
Buerger K; Ernst A; Ewers M; Uspenskaya O; Omerovic M; Morgenthaler NG; Knauer K; Bergmann A; Hampel H
Biol Psychiatry; 2009 Jun; 65(11):979-84. PubMed ID: 19344890
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department.
Dieplinger B; Gegenhuber A; Kaar G; Poelz W; Haltmayer M; Mueller T
Clin Biochem; 2010 Jun; 43(9):714-9. PubMed ID: 20153308
[TBL] [Abstract][Full Text] [Related]
12. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
[TBL] [Abstract][Full Text] [Related]
13. Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department.
Chung T; Sindone A; Foo F; Dwyer A; Paoloni R; Janu MR; Wong H; Hall J; Freedman SB
Am Heart J; 2006 Nov; 152(5):949-55. PubMed ID: 17070166
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department.
Lokuge A; Lam L; Cameron P; Krum H; de Villiers S; Bystrzycki A; Naughton MT; Eccleston D; Flannery G; Federman J; Schneider HG
Circ Heart Fail; 2010 Jan; 3(1):104-10. PubMed ID: 19933409
[TBL] [Abstract][Full Text] [Related]
15. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea.
Collins SP; Peacock WF; Lindsell CJ; Clopton P; Diercks DB; Hiestand B; Hogan C; Kontos MC; Mueller C; Nowak R; Chen WJ; Huang CH; Abraham WT; Amsterdam E; Breidthardt T; Daniels L; Hasan A; Hudson M; McCord J; Naz T; Wagoner LE; Maisel A
Ann Emerg Med; 2009 Jun; 53(6):748-57. PubMed ID: 19232777
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).
Richards M; Di Somma S; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Clopton P; Filippatos GS; Anand I; Ng L; Daniels LB; Neath SX; Shah K; Christenson R; Hartmann O; Anker SD; Maisel A
JACC Heart Fail; 2013 Jun; 1(3):192-9. PubMed ID: 24621869
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
[TBL] [Abstract][Full Text] [Related]
19. A clinical and biochemical score for mortality prediction in patients with acute dyspnoea: derivation, validation and incorporation into a bedside programme.
Baggish AL; Lloyd-Jones DM; Blatt J; Richards AM; Lainchbury J; O'Donoghue M; Sakhuja R; Chen AA; Januzzi JL
Heart; 2008 Aug; 94(8):1032-7. PubMed ID: 17947362
[TBL] [Abstract][Full Text] [Related]
20. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
